Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection

被引：63
|
作者：
Campbell, S [1 ]
Ghosh, S [1 ]
机构：
[1] Western Gen Hosp, Gastrointestinal Unit, Dept Med Sci, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2001年 / 13卷 / 02期
关键词：
Crohn's disease; hepatitis C; infliximab; tumour necrosis factor alpha;
D O I：
10.1097/00042737-200102000-00016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Treatment of Crohn's disease with infliximab is an important drug therapy for patients with refractory and fistulating disease. There are concerns over its use in a proportion of Crohn's patients with concurrent hepatitis C infection, since there are theoretical risks of accelerated hepatic decompensation due to the immunomodulatory impact of infliximab. We report a patient with both Crohn's disease and ongoing active hepatitis C infection who underwent infliximab therapy, with no worsening of his liver function or PCR status. Eur J Gastroenterol Hepatol 13:191-192 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码：191 / 192
页数：2
相关论文
共 50 条
  • [41] Maintenance therapy versus episodic therapy with infliximab for Crohn's disease
    Ghosh, Subrata
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 80 - 81
  • [42] Maintenance therapy versus episodic therapy with infliximab for Crohn's disease
    Subrata Ghosh
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 80 - 81
  • [43] Effect of infliximab therapy for rheumatoid arthritis (RA) on chronic hepatitis C (HCV) infection.
    Hayat, S
    Wolf, RE
    Yin, L
    Chen, H
    Berney, S
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S80 - S80
  • [44] Chronic hepatitis C and Crohn's disease:: Nosocomial infection treatment with PEG-interferon plus ribavirin
    Salcedo-Mora, Xamila
    Mate, Jose
    Medina, Jesus
    Chab, Syong J. Nam
    Gisbert, Javier P.
    Moreno-Otero, Ricardo
    DIGESTION, 2006, 73 (04) : 210 - 214
  • [45] Infliximab in Crohn's disease
    Sáez, LR
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (06) : 359 - 363
  • [46] Infliximab for Crohn's disease
    Verspaget, HW
    van der Zon, AM
    Gao, Q
    van Hogezand, RA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) : 2041 - 2042
  • [47] Failure of Infliximab Treatment in Crohn's Disease Is Associated With the Presence of Fibrosis
    de Bruyn, Jessica R.
    Meijer, Sybren L.
    Wildenberg, Manon E.
    van den Brink, Gijs R.
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2014, 146 (05) : S442 - S442
  • [48] Failure of infliximab treatment in Crohn's disease is associated with the presence of fibrosis
    de Bruyn, J.
    Meijer, S.
    Wildenberg, M.
    van den Brink, G.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S267 - S267
  • [49] Colon Cancer After Infliximab Therapy for Crohn’s Disease
    Frederico Ferreira
    Susana Lopes
    Guilherme Macedo
    BioDrugs, 2010, 24 : 18 - 21
  • [50] Failure of infliximab treatment in Crohn's disease is associated with the presence of fibrosis
    de Bruyn, J.
    Steenkamer, J.
    Wildenberg, M.
    Meijer, S.
    Bemelman, W.
    van den Brink, G.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S382 - S383
12345